460 related articles for article (PubMed ID: 30979857)
1. Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABA
de Bruijn MAAM; van Sonderen A; van Coevorden-Hameete MH; Bastiaansen AEM; Schreurs MWJ; Rouhl RPW; van Donselaar CA; Majoie MHJM; Neuteboom RF; Sillevis Smitt PAE; Thijs RD; Titulaer MJ
Neurology; 2019 May; 92(19):e2185-e2196. PubMed ID: 30979857
[TBL] [Abstract][Full Text] [Related]
2. Seizures and risk of epilepsy in anti-NMDAR, anti-LGI1, and anti-GABA
Shen CH; Fang GL; Yang F; Cai MT; Zheng Y; Fang W; Guo Y; Zhang YX; Ding MP
Ann Clin Transl Neurol; 2020 Aug; 7(8):1392-1399. PubMed ID: 32710704
[TBL] [Abstract][Full Text] [Related]
3. Risk of Seizure Recurrence Due to Autoimmune Encephalitis With NMDAR, LGI1, CASPR2, and GABA
Rada A; Hagemann A; Aaberg Poulsen C; Baumgartner T; Berki T; Blaabjerg M; Brenner J; Britton JW; Christiana A; Ciano-Petersen NL; Crijnen Y; Elišák M; Farina A; Friedman AR; Hayden Z; Hébert J; Holtkamp M; Hong Z; Honnorat J; Ilyas-Feldmann M; Irani SR; Kovac S; Marusic P; Muñiz-Castrillo S; Ramanathan S; Smith KM; Steriade C; Strippel C; Surges R; Titulaer MJ; Uy CE; de Vries JM; Bien CG; Specht U
Neurol Neuroimmunol Neuroinflamm; 2024 Jul; 11(4):e200225. PubMed ID: 38838283
[TBL] [Abstract][Full Text] [Related]
4. Seizure characteristics, treatment, and outcome in autoimmune synaptic encephalitis: A long-term study.
Zhang W; Wang X; Shao N; Ma R; Meng H
Epilepsy Behav; 2019 May; 94():198-203. PubMed ID: 30974347
[TBL] [Abstract][Full Text] [Related]
5. Acute Symptomatic Seizures and Risk of Seizure Recurrence in Patients with Anti-NMDAR, Anti-LGI1, and Anti-GABA
Cui D; Feng J; Yang M; Dong Y; Lian Y
Neurol Sci; 2024 Apr; 45(4):1609-1617. PubMed ID: 37940748
[TBL] [Abstract][Full Text] [Related]
6. Clinical features and long-term outcomes of seizures associated with autoimmune encephalitis: A follow-up study in East China.
Yao L; Yue W; Xunyi W; Jianhong W; Guoxing Z; Zhen H
J Clin Neurosci; 2019 Oct; 68():73-79. PubMed ID: 31331752
[TBL] [Abstract][Full Text] [Related]
7. Clinical and Electroencephalographic Features of the Seizures in Neuronal Surface Antibody-Associated Autoimmune Encephalitis.
Wang Y; Yu Y; Hu Y; Li Y; Song F; Wang Y
Front Neurol; 2020; 11():280. PubMed ID: 32431657
[No Abstract] [Full Text] [Related]
8. Long-term seizure outcomes in patients with autoimmune encephalitis: A prospective observational registry study update.
Liu X; Guo K; Lin J; Gong X; Li A; Zhou D; Hong Z
Epilepsia; 2022 Jul; 63(7):1812-1821. PubMed ID: 35357695
[TBL] [Abstract][Full Text] [Related]
9. Antiepileptic drug therapy in autoimmune epilepsy associated with antibodies targeting the leucine-rich glioma-inactivated protein 1.
Feyissa AM; Lamb C; Pittock SJ; Gadoth A; McKeon A; Klein CJ; Britton JW
Epilepsia Open; 2018 Sep; 3(3):348-356. PubMed ID: 30187005
[TBL] [Abstract][Full Text] [Related]
10. Seizure outcomes in patients with anti-NMDAR encephalitis: A follow-up study.
Liu X; Yan B; Wang R; Li C; Chen C; Zhou D; Hong Z
Epilepsia; 2017 Dec; 58(12):2104-2111. PubMed ID: 29098690
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of Seizure and Antiepileptic Drug Utilization in Outpatients With Autoimmune Encephalitis.
Huang Q; Ma M; Wei X; Liao Y; Qi H; Wu Y; Wu Y
Front Neurol; 2018; 9():1136. PubMed ID: 30671012
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and outcome-related factors of seizure at the first onset of autoimmune encephalitis: A retrospective study.
Wang Y; Li X; He P; Yin J; Dong R; Fu Y; Zhang H
CNS Neurosci Ther; 2021 Jun; 27(6):694-701. PubMed ID: 33683811
[TBL] [Abstract][Full Text] [Related]
13. Risk Factors for Mortality in Anti-NMDAR, Anti-LGI1, and Anti-GABABR Encephalitis.
Zhong R; Chen Q; Zhang X; Zhang H; Lin W
Front Immunol; 2022; 13():845365. PubMed ID: 35320933
[TBL] [Abstract][Full Text] [Related]
14. Associations between seizures and MRI in patients with anti-NMDAR encephalitis.
Ni G; Lin W; Cai X; Qin J; Feng L; Zhu S; Zhou L; Chen Z
Acta Neurol Scand; 2020 Nov; 142(5):460-465. PubMed ID: 32533702
[TBL] [Abstract][Full Text] [Related]
15. Neurological, psychiatric, and sleep investigations after treatment of anti-leucine-rich glioma-inactivated protein 1 (LGI1) encephalitis in Spain: a prospective cohort study.
Muñoz-Lopetegi A; Guasp M; Prades L; Martínez-Hernández E; Rosa-Justícia M; Patricio V; Armangué T; Rami L; Borràs R; Castro-Fornieles J; Compte A; Gaig C; Santamaria J; Dalmau J;
Lancet Neurol; 2024 Mar; 23(3):256-266. PubMed ID: 38365378
[TBL] [Abstract][Full Text] [Related]
16. Increased adverse events associated with antiepileptic drugs in anti-leucine-rich glioma-inactivated protein 1 encephalitis.
Shin YW; Ahn SJ; Moon J; Kim TJ; Jun JS; Byun JI; Lee ST; Jung KH; Park KI; Jung KY; Kim M; Lee SK; Chu K
Epilepsia; 2018 Oct; 59 Suppl 2():108-112. PubMed ID: 30159879
[TBL] [Abstract][Full Text] [Related]
17. Seizure Semiology in Antibody-Associated Autoimmune Encephalitis.
Kaaden T; Madlener M; Angstwurm K; Bien CG; Bogarin Y; Doppler K; Finke A; Gerner ST; Reimann G; Häusler M; Handreka R; Hellwig K; Kaufmann M; Kellinghaus C; Koertvelyessy P; Kraft A; Lewerenz J; Menge T; Paliantonis A; von Podewils F; Prüss H; Rauer S; Ringelstein M; Rostásy K; Schirotzek I; Schwabe J; Sokolowski P; Suesse M; Sühs KW; Surges R; Tauber SC; Thaler F; Bergh FT; Urbanek C; Wandinger KP; Wildemann B; Mues S; Zettl U; Leypoldt F; Melzer N; Geis C; Malter M; Kunze A;
Neurol Neuroimmunol Neuroinflamm; 2022 Nov; 9(6):. PubMed ID: 36266054
[TBL] [Abstract][Full Text] [Related]
18. Antibody induced seizure susceptibility and impaired cognitive performance in a passive transfer rat model of autoimmune encephalitis.
Pişkin ŞA; Korkmaz HY; Ulusoy CA; Şanlı E; Küçükali CI; Onat F; Tüzün E; Çarçak N
Front Immunol; 2023; 14():1268986. PubMed ID: 38035091
[TBL] [Abstract][Full Text] [Related]
19. Determinants for Control of Status Epilepticus in Patients with Anti-N-Methyl-D-Aspartate Receptor Encephalitis.
Yen HK; Tang SC; Tsai LK; Fan SP; Yeh SJ; Jeng JS
Acta Neurol Taiwan; 2021 Mar; 30(1)():1-10. PubMed ID: 34549395
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune Encephalitis Resembling Dementia Syndromes.
Bastiaansen AEM; van Steenhoven RW; de Bruijn MAAM; Crijnen YS; van Sonderen A; van Coevorden-Hameete MH; Nühn MM; Verbeek MM; Schreurs MWJ; Sillevis Smitt PAE; de Vries JM; Jan de Jong F; Titulaer MJ
Neurol Neuroimmunol Neuroinflamm; 2021 Sep; 8(5):. PubMed ID: 34341093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]